QIMR Berghofer Medical Research Institute
Herston, Australia
Purpose
to establish dose/concentration-response of single doses of tafenoquine in induced blood-stage malaria infections to facilitate dose-selection of to-be-expanded indications of this important antimalarial drug
Division
Global Health
Date
November 2019
Region Served
GLOBAL
Committed amount
$1,482,689
Grant topic
Malaria
Duration (months)
24
Grantee location
Herston, Australia
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.